RECRUITINGOBSERVATIONAL
ADNP Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing ADNP-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.
The Seaver Autism Center for Research and Treatment - Assessment Core
About This Trial
ADNP, also known as Activity Dependent Neuroprotective Protein, is a rare neurodevelopmental disorder caused by mutations encompassing the ADNP gene on chromosome 20. Clinically, ADNP syndrome is characterized by intellectual disability and global developmental delay. This study seeks to characterize ADNP-related neurodevelopmental disorders using a number of genetic, medical and neuropsychological measures.
Who May Be Eligible (Plain English)
Who May Qualify:
- Eligible participants must have a documented variant affecting the ADNP gene that the research team determines to be likely or definitely pathogenic.
- Eligible participants must be at least 2 years of age.
Who Should NOT Join This Trial:
- none
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Eligible participants must have a documented variant affecting the ADNP gene that the research team determines to be likely or definitely pathogenic.
* Eligible participants must be at least 2 years of age.
Exclusion Criteria:
* none
Locations (1)
The Seaver Autism Center for Research and Treatment
New York, New York, United States